| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 2.12e-04 | 6 | 76 | 2 | GO:0008349 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 2.23e-04 | 78 | 76 | 4 | GO:0051536 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.39e-04 | 229 | 76 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | metal cluster binding | 2.84e-04 | 83 | 76 | 4 | GO:0051540 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.77e-04 | 739 | 76 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 7.49e-04 | 645 | 76 | 9 | GO:0140640 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | KDM5B ZFP42 ERCC6 KMT5B ANP32B UBTF SETBP1 ASH1L NFRKB PRKCA SRPK1 ZDBF2 JADE1 TTF1 | 1.07e-05 | 999 | 74 | 14 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | KDM5B ZFP42 ERCC6 KMT5B ANP32B SETBP1 ASH1L NFRKB PRKCA ZDBF2 JADE1 TTF1 | 1.20e-05 | 741 | 74 | 12 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | KDM5B ZFP42 ERCC6 KMT5B ANP32B SETBP1 ASH1L NFRKB PRKCA SRPK1 ZDBF2 JADE1 TTF1 | 1.61e-05 | 896 | 74 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | DNA repair | CUL4B CUL4A RAD51AP1 TICRR BRIP1 ERCC6 KMT5B NFRKB MARF1 REV3L GEN1 | 1.87e-05 | 648 | 74 | 11 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA metabolic process | CUL4B CUL4A RAD51AP1 TICRR BRIP1 ERCC6 KMT5B NFRKB MARF1 JADE1 REV3L CDC42 TTF1 GEN1 | 2.59e-05 | 1081 | 74 | 14 | GO:0006259 |
| GeneOntologyBiologicalProcess | cell cycle process | CUL4B CUL4A RAD51AP1 TICRR BRIP1 ERCC6 ANP32B MARF1 PRKCA SRPK1 JADE1 CCDC102B CENATAC CDC42 GEN1 DEUP1 | 4.16e-05 | 1441 | 74 | 16 | GO:0022402 |
| GeneOntologyBiologicalProcess | JNK cascade | 7.81e-05 | 198 | 74 | 6 | GO:0007254 | |
| GeneOntologyBiologicalProcess | DNA replication | 1.28e-04 | 312 | 74 | 7 | GO:0006260 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 1.62e-04 | 324 | 74 | 7 | GO:0006302 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 1.82e-04 | 564 | 74 | 9 | GO:0051052 | |
| GeneOntologyBiologicalProcess | regulation of DNA replication | 1.86e-04 | 147 | 74 | 5 | GO:0006275 | |
| GeneOntologyBiologicalProcess | uterus morphogenesis | 1.89e-04 | 6 | 74 | 2 | GO:0061038 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | CUL4B CUL4A RAD51AP1 TICRR BRIP1 ERCC6 ANP32B JADE1 CENATAC CDC42 GEN1 | 2.02e-04 | 845 | 74 | 11 | GO:0010564 |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 3.18e-04 | 362 | 74 | 7 | GO:0010948 | |
| GeneOntologyBiologicalProcess | DNA recombination | 3.51e-04 | 368 | 74 | 7 | GO:0006310 | |
| GeneOntologyBiologicalProcess | positive regulation of toll-like receptor 3 signaling pathway | 3.51e-04 | 8 | 74 | 2 | GO:0034141 | |
| MousePheno | abnormal skin morphology | CUL4B NCOA2 IFIH1 ERCC6 KCNH8 CISD2 UBTF ASH1L PRKCA XDH SLCO1B3 DCN VPS13B PXK DHX8 PLCE1 BRWD1 | 2.60e-05 | 1455 | 55 | 17 | MP:0002060 |
| Domain | MAPKKKK | 9.00e-05 | 4 | 73 | 2 | IPR021160 | |
| Domain | Zinc_finger_PHD-type_CS | 1.21e-04 | 65 | 73 | 4 | IPR019786 | |
| Domain | PHD | 2.12e-04 | 75 | 73 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 2.59e-04 | 79 | 73 | 4 | IPR019787 | |
| Domain | Cullin_CS | 3.12e-04 | 7 | 73 | 2 | IPR016157 | |
| Domain | CULLIN | 3.12e-04 | 7 | 73 | 2 | SM00182 | |
| Domain | PHD | 4.08e-04 | 89 | 73 | 4 | SM00249 | |
| Domain | Cullin_Nedd8 | 4.16e-04 | 8 | 73 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 4.16e-04 | 8 | 73 | 2 | SM00884 | |
| Domain | Cullin_neddylation_domain | 4.16e-04 | 8 | 73 | 2 | IPR019559 | |
| Domain | Znf_PHD | 4.44e-04 | 91 | 73 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 5.23e-04 | 95 | 73 | 4 | PS50016 | |
| Domain | Cullin_homology | 5.33e-04 | 9 | 73 | 2 | IPR016158 | |
| Domain | ZF_PHD_1 | 5.44e-04 | 96 | 73 | 4 | PS01359 | |
| Domain | Cullin | 6.64e-04 | 10 | 73 | 2 | PF00888 | |
| Domain | CULLIN_2 | 6.64e-04 | 10 | 73 | 2 | PS50069 | |
| Domain | Cullin_N | 6.64e-04 | 10 | 73 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 6.64e-04 | 10 | 73 | 2 | PS01256 | |
| Domain | PX | 6.76e-04 | 44 | 73 | 3 | SM00312 | |
| Domain | BAH | 8.10e-04 | 11 | 73 | 2 | SM00439 | |
| Domain | BAH | 8.10e-04 | 11 | 73 | 2 | PF01426 | |
| Domain | BAH | 8.10e-04 | 11 | 73 | 2 | PS51038 | |
| Domain | BAH_dom | 8.10e-04 | 11 | 73 | 2 | IPR001025 | |
| Domain | DEXDc | 8.77e-04 | 109 | 73 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 9.07e-04 | 110 | 73 | 4 | IPR014001 | |
| Domain | PX | 9.28e-04 | 49 | 73 | 3 | PF00787 | |
| Domain | Cullin_repeat-like_dom | 9.70e-04 | 12 | 73 | 2 | IPR016159 | |
| Domain | - | 9.70e-04 | 12 | 73 | 2 | 3.40.50.1010 | |
| Domain | PX | 9.84e-04 | 50 | 73 | 3 | PS50195 | |
| Domain | - | 1.04e-03 | 51 | 73 | 3 | 3.30.1520.10 | |
| Domain | Phox | 1.10e-03 | 52 | 73 | 3 | IPR001683 | |
| Domain | PIN_domain-like | 1.33e-03 | 14 | 73 | 2 | IPR029060 | |
| Domain | CNH | 1.33e-03 | 14 | 73 | 2 | SM00036 | |
| Domain | CNH | 1.53e-03 | 15 | 73 | 2 | PF00780 | |
| Domain | CNH | 1.53e-03 | 15 | 73 | 2 | PS50219 | |
| Domain | CNH_dom | 1.53e-03 | 15 | 73 | 2 | IPR001180 | |
| Domain | UDENN | 1.75e-03 | 16 | 73 | 2 | PS50946 | |
| Domain | DDENN | 1.75e-03 | 16 | 73 | 2 | PS50947 | |
| Domain | DENN | 1.75e-03 | 16 | 73 | 2 | SM00799 | |
| Domain | dDENN | 1.75e-03 | 16 | 73 | 2 | SM00801 | |
| Domain | DENN | 1.75e-03 | 16 | 73 | 2 | PF02141 | |
| Domain | dDENN_dom | 1.75e-03 | 16 | 73 | 2 | IPR005112 | |
| Domain | uDENN_dom | 1.75e-03 | 16 | 73 | 2 | IPR005113 | |
| Domain | dDENN | 1.75e-03 | 16 | 73 | 2 | PF03455 | |
| Domain | DENN | 1.75e-03 | 16 | 73 | 2 | PS50211 | |
| Domain | DENN_dom | 1.75e-03 | 16 | 73 | 2 | IPR001194 | |
| Domain | Znf_FYVE_PHD | 2.63e-03 | 147 | 73 | 4 | IPR011011 | |
| Pathway | REACTOME_DNA_REPAIR | 1.35e-06 | 301 | 52 | 9 | MM15433 | |
| Pathway | REACTOME_DNA_REPAIR | 3.02e-06 | 332 | 52 | 9 | M15434 | |
| Pathway | REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX | 3.62e-05 | 51 | 52 | 4 | M27599 | |
| Pathway | REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX | 3.62e-05 | 51 | 52 | 4 | MM15315 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.26e-05 | 175 | 52 | 6 | MM14941 | |
| Pathway | REACTOME_NUCLEOTIDE_EXCISION_REPAIR | 4.69e-05 | 108 | 52 | 5 | M7927 | |
| Pathway | REACTOME_NUCLEOTIDE_EXCISION_REPAIR | 4.69e-05 | 108 | 52 | 5 | MM15304 | |
| Pathway | WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK | 7.76e-05 | 120 | 52 | 5 | M40049 | |
| Pathway | REACTOME_DUAL_INCISION_IN_TC_NER | 8.35e-05 | 63 | 52 | 4 | MM15317 | |
| Pathway | REACTOME_DUAL_INCISION_IN_TC_NER | 8.35e-05 | 63 | 52 | 4 | M27601 | |
| Pathway | REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER | 1.65e-04 | 75 | 52 | 4 | MM15316 | |
| Pathway | REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER | 1.74e-04 | 76 | 52 | 4 | M27600 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER | 1.98e-04 | 31 | 52 | 3 | M47825 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 2.85e-04 | 35 | 52 | 3 | MM15293 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 3.37e-04 | 37 | 52 | 3 | M27583 | |
| Pathway | REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER | 3.65e-04 | 38 | 52 | 3 | M27592 | |
| Pathway | REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER | 3.65e-04 | 38 | 52 | 3 | MM15301 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.72e-04 | 272 | 52 | 6 | M29619 | |
| Pathway | KEGG_NUCLEOTIDE_EXCISION_REPAIR | 5.64e-04 | 44 | 52 | 3 | M18937 | |
| Pathway | WP_NUCLEOTIDE_EXCISION_REPAIR | 5.64e-04 | 44 | 52 | 3 | M39847 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION | 6.85e-04 | 47 | 52 | 3 | M1095 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | 6.85e-04 | 47 | 52 | 3 | MM15428 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M | 7.19e-04 | 11 | 52 | 2 | M47573 | |
| Pathway | BIOCARTA_MYOSIN_PATHWAY | 7.19e-04 | 11 | 52 | 2 | M7014 | |
| Pathway | REACTOME_DNA_DAMAGE_BYPASS | 7.28e-04 | 48 | 52 | 3 | M27698 | |
| Pathway | REACTOME_DNA_DAMAGE_BYPASS | 7.28e-04 | 48 | 52 | 3 | MM15432 | |
| Pathway | WP_MRNA_PROCESSING | 1.18e-03 | 126 | 52 | 4 | M39406 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 1.33e-03 | 59 | 52 | 3 | MM15283 | |
| Pubmed | 3.48e-08 | 42 | 76 | 5 | 34581821 | ||
| Pubmed | 4.80e-08 | 332 | 76 | 9 | 25693804 | ||
| Pubmed | NCOA2 ARHGAP5 TICRR MAP4K3 UBTF ASH1L NFRKB AKNAD1 JADE1 CDC42 GEN1 VPS13B LRRC18 BRWD1 | 8.54e-08 | 1084 | 76 | 14 | 11544199 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | BRIX1 TICRR ERCC6 WDR36 PHF3 UBTF RPP38 SRPK1 PRPF8 TTF1 C8orf33 DHX8 | 9.26e-08 | 759 | 76 | 12 | 35915203 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4B CUL4A RAD51AP1 BRIP1 WDR36 PHF3 UBTF POLR2A SIMC1 NFRKB MARF1 ZDBF2 PRPF8 | 1.42e-07 | 954 | 76 | 13 | 36373674 |
| Pubmed | CUL4B BRIX1 WDR36 PHF3 UBTF POLR2A SRPK1 IPO4 PRPF8 TTF1 DHX8 | 1.78e-07 | 653 | 76 | 11 | 22586326 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.86e-07 | 410 | 76 | 9 | 26949251 | |
| Pubmed | Structural basis of human transcription-DNA repair coupling. | 3.49e-07 | 7 | 76 | 3 | 34526721 | |
| Pubmed | The cooperative action of CSB, CSA, and UVSSA target TFIIH to DNA damage-stalled RNA polymerase II. | 6.33e-07 | 31 | 76 | 4 | 32355176 | |
| Pubmed | 7.95e-07 | 339 | 76 | 8 | 30415952 | ||
| Pubmed | 8.34e-07 | 9 | 76 | 3 | 34233190 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.41e-06 | 497 | 76 | 9 | 36774506 | |
| Pubmed | 2.66e-06 | 99 | 76 | 5 | 34161765 | ||
| Pubmed | CSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination. | 3.59e-06 | 14 | 76 | 3 | 22032989 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28402280 | ||
| Pubmed | Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Colombian families. | 4.71e-06 | 2 | 76 | 2 | 25042601 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20064923 | ||
| Pubmed | Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. | 4.71e-06 | 2 | 76 | 2 | 27974468 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9372911 | ||
| Pubmed | 5.50e-06 | 16 | 76 | 3 | 33288900 | ||
| Pubmed | 6.67e-06 | 17 | 76 | 3 | 22902626 | ||
| Pubmed | 7.62e-06 | 57 | 76 | 4 | 18022353 | ||
| Pubmed | Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. | 9.47e-06 | 19 | 76 | 3 | 14578343 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.37e-05 | 358 | 76 | 7 | 32460013 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24316392 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 34119472 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 32587774 | ||
| Pubmed | Cullin4B/E3-ubiquitin ligase negatively regulates beta-catenin. | 1.41e-05 | 3 | 76 | 2 | 17954973 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 28553952 | ||
| Pubmed | E3 ubiquitin ligase Cullin4B mediated polyubiquitination of p53 for its degradation. | 1.41e-05 | 3 | 76 | 2 | 24452595 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 29973096 | ||
| Pubmed | 1.66e-05 | 144 | 76 | 5 | 35681168 | ||
| Pubmed | 1.91e-05 | 251 | 76 | 6 | 28077445 | ||
| Pubmed | NCOA2 ARHGAP5 KDM5B NISCH ASH1L DENND6B TLN2 REV3L DCN PRPF8 GEN1 BRWD1 | 2.15e-05 | 1285 | 76 | 12 | 35914814 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.18e-05 | 533 | 76 | 8 | 30554943 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CUL4A BRIX1 TICRR WDR36 PHF3 UBTF POLR2A RPP38 NFRKB PRPF8 TTF1 DHX8 | 2.30e-05 | 1294 | 76 | 12 | 30804502 |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 28292928 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 20033399 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 30945295 | ||
| Pubmed | GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression. | 2.82e-05 | 4 | 76 | 2 | 19074285 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 34420308 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 26620705 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 19818632 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 28076779 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 11284700 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 22453236 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 22262661 | ||
| Pubmed | CUL4B CUL4A RAD51AP1 ERCC6 KMT5B POLR2A RPP38 ASH1L NFRKB REV3L BRWD1 | 3.00e-05 | 1116 | 76 | 11 | 31753913 | |
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 16246722 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 32466489 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 24719410 | ||
| Pubmed | Two novel human NUMB isoforms provide a potential link between development and cancer. | 4.69e-05 | 5 | 76 | 2 | 21122105 | |
| Pubmed | The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation. | 4.69e-05 | 5 | 76 | 2 | 22118460 | |
| Pubmed | Cullin 4A and 4B ubiquitin ligases interact with γ-tubulin and induce its polyubiquitination. | 4.69e-05 | 5 | 76 | 2 | 25542213 | |
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 28191889 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 27142104 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 26711351 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 34171797 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 36056023 | ||
| Pubmed | Selective degradation of splicing factor CAPERα by anticancer sulfonamides. | 4.69e-05 | 5 | 76 | 2 | 28437394 | |
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 26021757 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 30923324 | ||
| Pubmed | Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. | 4.75e-05 | 32 | 76 | 3 | 16964240 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 4.87e-05 | 91 | 76 | 4 | 20362542 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 5.53e-05 | 608 | 76 | 8 | 36089195 | |
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | 6.38e-05 | 191 | 76 | 5 | 21907836 | |
| Pubmed | Radiation-mediated proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new checkpoint. | 7.03e-05 | 6 | 76 | 2 | 14578910 | |
| Pubmed | cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. | 7.03e-05 | 6 | 76 | 2 | 8681378 | |
| Pubmed | PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated N-terminal ubiquitination. | 7.03e-05 | 6 | 76 | 2 | 16407252 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 14576433 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 22606329 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 18593899 | ||
| Pubmed | CRL4(RBBP7) is required for efficient CENP-A deposition at centromeres. | 7.03e-05 | 6 | 76 | 2 | 25795299 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 34251884 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 30295604 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 23562818 | ||
| Pubmed | Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. | 7.03e-05 | 6 | 76 | 2 | 20228790 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 20932471 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 10944529 | ||
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 26826127 | ||
| Pubmed | TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A. | 7.39e-05 | 37 | 76 | 3 | 29531219 | |
| Pubmed | 7.91e-05 | 472 | 76 | 7 | 38943005 | ||
| Pubmed | ERCC6 WDR36 PHF3 POLR2A RPP38 NFRKB SRPK1 IPO4 CDC42 TTF1 C8orf33 DHX8 | 9.35e-05 | 1497 | 76 | 12 | 31527615 | |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 30898011 | ||
| Pubmed | SPT16 ubiquitylation by DCAF14-CRL4 regulates FACT binding to histones. | 9.83e-05 | 7 | 76 | 2 | 35320725 | |
| Pubmed | Identification of toposome, a novel multisubunit complex containing topoisomerase IIalpha. | 9.83e-05 | 7 | 76 | 2 | 15034300 | |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 27294876 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 23667505 | ||
| Pubmed | Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy. | 9.83e-05 | 7 | 76 | 2 | 37024504 | |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 21228219 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 23297343 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 25014791 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 23555860 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 29225035 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 32140073 | ||
| Pubmed | mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase. | 1.31e-04 | 8 | 76 | 2 | 18235224 | |
| Pubmed | The Cul4-DDB1-WDR3/WDR6 Complex Binds SPAK and OSR1 Kinases in a Phosphorylation-Dependent Manner. | 1.31e-04 | 8 | 76 | 2 | 31614064 | |
| Pubmed | Regulation of CLC-1 chloride channel biosynthesis by FKBP8 and Hsp90β. | 1.31e-04 | 8 | 76 | 2 | 27580824 | |
| Pubmed | Covalent modification of all members of human cullin family proteins by NEDD8. | 1.31e-04 | 8 | 76 | 2 | 10597293 | |
| Pubmed | CRL4DCAF8 Ubiquitin Ligase Targets Histone H3K79 and Promotes H3K9 Methylation in the Liver. | 1.31e-04 | 8 | 76 | 2 | 28178526 | |
| Interaction | NUP43 interactions | CUL4A BRIP1 WDR36 UBTF RPP38 ASH1L NFRKB MARF1 ZDBF2 CCDC168 FAM199X TTF1 DHX8 | 4.69e-07 | 625 | 75 | 13 | int:NUP43 |
| Interaction | H3C1 interactions | CUL4B CUL4A BRIX1 TNRC18 BRIP1 ERCC6 ANP32B PHF3 UBTF POLR2A ASH1L PRKCA SRPK1 JADE1 IPO4 | 9.38e-07 | 901 | 75 | 15 | int:H3C1 |
| Interaction | PPIA interactions | CUL4B BRIX1 IFIH1 ZFP42 BRIP1 ERCC6 WDR36 PHF3 POLR2A SRPK1 TLN2 PRPF8 CDC42 DHX8 | 4.30e-06 | 888 | 75 | 14 | int:PPIA |
| Interaction | CBX3 interactions | CUL4B CUL4A RAD51AP1 BRIP1 WDR36 PHF3 UBTF POLR2A NFRKB SRPK1 CDC42 DHX8 | 4.38e-06 | 646 | 75 | 12 | int:CBX3 |
| Interaction | ERCC8 interactions | 6.84e-06 | 124 | 75 | 6 | int:ERCC8 | |
| Interaction | SMC5 interactions | CUL4B CUL4A RAD51AP1 BRIP1 WDR36 PHF3 UBTF POLR2A SIMC1 NFRKB MARF1 ZDBF2 REV3L PRPF8 | 1.65e-05 | 1000 | 75 | 14 | int:SMC5 |
| Interaction | SIRT7 interactions | CUL4B CUL4A BRIX1 WDR36 PHF3 UBTF POLR2A SRPK1 IPO4 PRPF8 TTF1 DHX8 | 1.81e-05 | 744 | 75 | 12 | int:SIRT7 |
| Interaction | SNRNP40 interactions | CUL4B CUL4A BRIP1 WDR36 UBTF RPP38 NFRKB SRPK1 ZDBF2 PRPF8 DHX8 | 2.25e-05 | 637 | 75 | 11 | int:SNRNP40 |
| Interaction | H1-4 interactions | BRIX1 VWA3A TNRC18 PHF3 UBTF PRKCA SRPK1 REV3L TTF1 C8orf33 DHX8 | 2.95e-05 | 656 | 75 | 11 | int:H1-4 |
| Interaction | MAP4K2 interactions | 3.23e-05 | 98 | 75 | 5 | int:MAP4K2 | |
| Interaction | MAGEB2 interactions | 4.59e-05 | 349 | 75 | 8 | int:MAGEB2 | |
| Interaction | H2BC21 interactions | CUL4B CUL4A BRIX1 TICRR KDM5B PHF3 POLR2A JADE1 PRPF8 TTF1 C8orf33 | 5.05e-05 | 696 | 75 | 11 | int:H2BC21 |
| Interaction | DDX23 interactions | 7.13e-05 | 480 | 75 | 9 | int:DDX23 | |
| Cytoband | 10q11.23 | 1.42e-03 | 33 | 77 | 2 | 10q11.23 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 3.64e-05 | 25 | 47 | 3 | 504 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 6.58e-05 | 5 | 47 | 2 | 655 | |
| GeneFamily | PHD finger proteins | 8.69e-05 | 90 | 47 | 4 | 88 | |
| GeneFamily | Cullins | 1.83e-04 | 8 | 47 | 2 | 1032 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.52e-03 | 34 | 47 | 2 | 487 | |
| Coexpression | OUYANG_PROSTATE_CANCER_PROGRESSION_UP | 3.76e-07 | 21 | 76 | 4 | MM1228 | |
| Coexpression | OUYANG_PROSTATE_CANCER_PROGRESSION_UP | 3.76e-07 | 21 | 76 | 4 | M15626 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 5.20e-06 | 86 | 76 | 5 | M39247 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 6.73e-06 | 158 | 76 | 6 | M372 | |
| Coexpression | GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN | 1.17e-05 | 174 | 76 | 6 | M8931 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 2.10e-05 | 193 | 76 | 6 | M6813 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 2.23e-05 | 195 | 76 | 6 | M13736 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 2.29e-05 | 196 | 76 | 6 | MM667 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN | 2.57e-05 | 200 | 76 | 6 | M8849 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 2.64e-05 | 680 | 76 | 10 | M41089 | |
| Coexpression | KIM_WT1_TARGETS_DN | 6.63e-05 | 471 | 76 | 8 | M17859 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN | 1.06e-04 | 648 | 76 | 9 | M14371 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CUL4B ARHGAP5 RAD51AP1 TICRR CISD2 ANP32B PHF3 SETBP1 RPP38 ZDBF2 REV3L TTF1 GEN1 DHX8 BRWD1 | 3.30e-05 | 1257 | 76 | 15 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CUL4B ARHGAP5 RAD51AP1 TICRR CISD2 ANP32B PHF3 SETBP1 RPP38 ZDBF2 REV3L TTF1 GEN1 DEUP1 DHX8 BRWD1 | 4.81e-05 | 1459 | 76 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CUL4B NCOA2 RAD51AP1 DENND2A TICRR PHF3 SETBP1 SRPK1 ZDBF2 REV3L GEN1 DEUP1 DHX8 PLCE1 BRWD1 | 8.80e-05 | 1370 | 76 | 15 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-07 | 134 | 77 | 6 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 8.83e-07 | 187 | 77 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 9.11e-07 | 188 | 77 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.06e-06 | 193 | 77 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-06 | 196 | 77 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-06 | 150 | 77 | 5 | c3ad5fa41eb636a5d691c0268c0f1c32cd0de658 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-06 | 150 | 77 | 5 | 78b8029e71d26f336a46274c8afef3435bf536b9 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.36e-06 | 155 | 77 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.36e-06 | 155 | 77 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 7.83e-06 | 157 | 77 | 5 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.39e-06 | 163 | 77 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-05 | 166 | 77 | 5 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.25e-05 | 173 | 77 | 5 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.56e-05 | 181 | 77 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.60e-05 | 182 | 77 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 183 | 77 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 184 | 77 | 5 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.69e-05 | 184 | 77 | 5 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.82e-05 | 187 | 77 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.97e-05 | 190 | 77 | 5 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.97e-05 | 190 | 77 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 191 | 77 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 191 | 77 | 5 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 191 | 77 | 5 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 191 | 77 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-05 | 191 | 77 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 191 | 77 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-05 | 192 | 77 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.07e-05 | 192 | 77 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.12e-05 | 193 | 77 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.12e-05 | 193 | 77 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.12e-05 | 193 | 77 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.23e-05 | 195 | 77 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.23e-05 | 195 | 77 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.23e-05 | 195 | 77 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.28e-05 | 196 | 77 | 5 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.28e-05 | 196 | 77 | 5 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.28e-05 | 196 | 77 | 5 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.28e-05 | 196 | 77 | 5 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.28e-05 | 196 | 77 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.40e-05 | 198 | 77 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 198 | 77 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-05 | 198 | 77 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.46e-05 | 199 | 77 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | distal-mesenchymal-Pericyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.46e-05 | 199 | 77 | 5 | 000d9b5f5a48e56f0733390adb3d7270c49a4a1a | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.52e-05 | 200 | 77 | 5 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-05 | 200 | 77 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-05 | 200 | 77 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.52e-05 | 200 | 77 | 5 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-05 | 200 | 77 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-05 | 200 | 77 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-05 | 200 | 77 | 5 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-05 | 200 | 77 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | distal-1-mesenchymal-Pericyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.52e-05 | 200 | 77 | 5 | ff205afda57b9267016f0c937445da1b0266af9b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-05 | 200 | 77 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-05 | 200 | 77 | 5 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.11e-05 | 132 | 77 | 4 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-valve_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 153 | 77 | 4 | 1440f2716fea74e2c3eb2924eba3d63ebd08c997 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-04 | 156 | 77 | 4 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 157 | 77 | 4 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 158 | 77 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 158 | 77 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-04 | 165 | 77 | 4 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-04 | 165 | 77 | 4 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-04 | 165 | 77 | 4 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-04 | 166 | 77 | 4 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-04 | 166 | 77 | 4 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 2.10e-04 | 169 | 77 | 4 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.10e-04 | 169 | 77 | 4 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 169 | 77 | 4 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | NS-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.15e-04 | 170 | 77 | 4 | f6a0162bb690dbc19ff1cec64cb933744ad3b496 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.15e-04 | 170 | 77 | 4 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.20e-04 | 171 | 77 | 4 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 171 | 77 | 4 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-04 | 171 | 77 | 4 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-04 | 172 | 77 | 4 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 174 | 77 | 4 | 6b362b8a934a4fe6a1dd867b7c448cb3fb3ffd6a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-04 | 175 | 77 | 4 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.40e-04 | 175 | 77 | 4 | 69ed3c7c45df6bef70f5f2ff003531160bf3b32b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-04 | 175 | 77 | 4 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.45e-04 | 176 | 77 | 4 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.45e-04 | 176 | 77 | 4 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-04 | 178 | 77 | 4 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 178 | 77 | 4 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.56e-04 | 178 | 77 | 4 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-04 | 180 | 77 | 4 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.73e-04 | 181 | 77 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.73e-04 | 181 | 77 | 4 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.73e-04 | 181 | 77 | 4 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.73e-04 | 181 | 77 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 181 | 77 | 4 | 709e9c7a60d5f98635b99895ce30bb87a9f7376d | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.78e-04 | 182 | 77 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 182 | 77 | 4 | cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.84e-04 | 183 | 77 | 4 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.84e-04 | 183 | 77 | 4 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 184 | 77 | 4 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 184 | 77 | 4 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-04 | 184 | 77 | 4 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.74e-06 | 184 | 76 | 7 | 2321_DN | |
| Disease | high grade glioma (is_implicated_in) | 1.56e-04 | 42 | 73 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | QRS complex, QRS duration | 1.91e-04 | 45 | 73 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | Graves Disease | 2.15e-04 | 9 | 73 | 2 | C0018213 | |
| Disease | Malignant neoplasm of breast | NCOA2 BRIP1 ERCC6 NISCH ANKEF1 SETBP1 XDH PKDREJ GEN1 VPS13B | 3.04e-04 | 1074 | 73 | 10 | C0006142 |
| Disease | JT interval | 3.80e-04 | 248 | 73 | 5 | EFO_0007885 | |
| Disease | Libman-Sacks Disease | 4.07e-04 | 58 | 73 | 3 | C0242380 | |
| Disease | Lupus Erythematosus, Systemic | 7.36e-04 | 71 | 73 | 3 | C0024141 | |
| Disease | exercise test | 1.11e-03 | 20 | 73 | 2 | EFO_0004328 | |
| Disease | urticaria | 1.11e-03 | 20 | 73 | 2 | EFO_0005531 | |
| Disease | colorectal carcinoma (is_implicated_in) | 1.35e-03 | 22 | 73 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | serum alanine aminotransferase measurement | 1.36e-03 | 869 | 73 | 8 | EFO_0004735 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.41e-03 | 195 | 73 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.61e-03 | 93 | 73 | 3 | C1535926 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 2.04e-03 | 27 | 73 | 2 | DOID:0050861 (is_marker_for) | |
| Disease | gamma-glutamyltyrosine measurement | 2.04e-03 | 27 | 73 | 2 | EFO_0021144 | |
| Disease | suicidal ideation | 2.35e-03 | 29 | 73 | 2 | EFO_0004320 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPRKPKTDKFQVLAK | 136 | Q15361 | |
| LQAKRTKKPPKNLEN | 91 | Q9NR48 | |
| LELGLKRQKPTPKQK | 121 | Q9H7E9 | |
| PQADPKSRQKKLLKK | 86 | A6NHR8 | |
| VQKLRKKEPKTLLPH | 286 | Q8TDN6 | |
| KLDNLPKPAENQKLK | 646 | Q9NU02 | |
| SVSNLPKLPKLKKLE | 56 | Q92688 | |
| PKLPKLKKLELSENR | 61 | Q92688 | |
| KQNKVPRKELPHLKE | 116 | Q05D60 | |
| PKQVKLKKPSRLKTL | 361 | Q8NEG7 | |
| LEKHLRPKQKPKNSK | 1196 | Q03468 | |
| KLPEDLKNFRPAKKI | 461 | Q8IWA6 | |
| PLNKKSRTAPKELKQ | 31 | Q96B01 | |
| KPKNIKKNRYKDILP | 51 | Q9Y2R2 | |
| KNPKKRPTAEKLLQH | 256 | Q12851 | |
| KNPKKRPTAEKLLQH | 256 | Q8IVH8 | |
| KARKALQQKPKPPSK | 671 | Q6P4R8 | |
| LKKPAKPLLSKIKLR | 441 | Q4FZB7 | |
| LPKKKNKHRNLDELP | 166 | Q6PEV8 | |
| LSKNQLKELPEKMPK | 136 | P07585 | |
| LPKLKKLNIKRNPFP | 166 | Q8N456 | |
| LKRKQRKLKEPLPNG | 1101 | Q9UGL1 | |
| IEKLAKNKQKPITPE | 126 | P60953 | |
| DKNGLLVLPKNKKRS | 566 | Q9BX63 | |
| LSDKKPTPQRVIKLK | 366 | Q6PI47 | |
| QKQILKSEKNKPLDP | 271 | P57057 | |
| LRKLSCLGENQKKPK | 6 | Q5JQS6 | |
| PQNGRKKRKIPKLVL | 471 | Q9ULE3 | |
| QQRKESKKPPAKLQP | 36 | Q9UBU3 | |
| NQLKFPVKPGDLKKR | 721 | Q13619 | |
| LKNNRLKKENKPVIP | 466 | Q9BYX4 | |
| KQLPKKPCKNLLSTL | 506 | Q5VZ89 | |
| PKNKIINKPLAIAKQ | 271 | Q5T1N1 | |
| LKLPKHKKLINRPQS | 651 | Q6ZMT9 | |
| NLKPKRLKSQTKIIP | 1456 | Q9NSI6 | |
| VESPAKKQPKNRVKL | 1716 | Q9Y4F3 | |
| KKQKRIKPKENNLPE | 466 | Q17RS7 | |
| KQKLKKLPPDRVGAN | 271 | Q86UT8 | |
| KENKRLKNISPKMLP | 611 | Q8NDH2 | |
| TLKKKQSLPPQKEAL | 136 | Q68D86 | |
| KVKSKALLKNRLLPP | 276 | Q8TEX9 | |
| QLKFPVKPADLKKRI | 876 | Q13620 | |
| PTKLSKQKKQQRLEP | 1186 | Q14562 | |
| LQPLKIKKLIPNPNK | 256 | P78345 | |
| VKLKLIPDPKNESKQ | 196 | P17252 | |
| PSPDQLRKKVLLKNK | 1526 | Q9P212 | |
| PSQKDLQQLKKKPRI | 1556 | Q9NTG1 | |
| RKLLPTLPPDKKLSK | 101 | Q02577 | |
| KDLIIKRIKPKPQQG | 796 | Q8NDZ2 | |
| VPKTNVKKLDPNLLK | 1046 | Q13017 | |
| NPLEPKNAEKLKVKI | 481 | Q96SB4 | |
| LKRKVNFNKPLITPK | 456 | Q6IE81 | |
| LPLKNILDEIKKPKN | 96 | Q96A58 | |
| VRPFLPKKKQQKDSL | 56 | Q8N5K1 | |
| KQEPVSPKKKENALL | 731 | Q15596 | |
| LNALKHRPPKAQKKR | 456 | Q6P2Q9 | |
| LKNLRLPRELKPNKK | 1441 | O15417 | |
| AQKLKDKAIKTPKRP | 1281 | Q7Z2Z1 | |
| PRSTKQKEKIPKLLK | 1586 | O60673 | |
| KFAEPRNKKPSVLKL | 321 | Q9Y5W7 | |
| VPRLKELINISKKPK | 1121 | P24928 | |
| KNPNKPQKERKISLS | 281 | Q9NPD5 | |
| IDKNLLPPKKIIGKN | 66 | Q9Y2I1 | |
| KPIILQQKPRKASEK | 2196 | Q9HCK1 | |
| LKLKKPEKNLQPRQR | 661 | Q92576 | |
| KPQFKIPTKLKEALR | 406 | Q7Z7A4 | |
| QTILKRLEPYKKKNP | 1096 | P47989 | |
| KQLAEFARKKPPINK | 166 | Q96MM3 | |
| RQTLLKKPKKRPNSP | 26 | P58753 | |
| RNKKLKSLENPPLKI | 171 | Q8N9V7 | |
| QAKLPKTQKEKRKSP | 1516 | Q7Z7G8 | |
| AKKLEQLKPRAKPKQ | 2321 | Q9Y4G6 | |
| LKKLKALNNFPKAIP | 841 | Q5TAH2 | |
| LIQNAKKSDIPEKPK | 186 | P17480 | |
| KIQTTKRAKKPPKNL | 106 | Q9Y6X0 | |
| KEKPKTLQLRSQPKK | 736 | A6NCI4 | |
| LNLDVIKKKNKPKEP | 766 | Q8NI36 | |
| IDPPNHNKRKEKNLK | 781 | Q96L42 |